G-CSF is typically administered via subcutaneous injection or intravenous infusion. The dosage and frequency depend on various factors, such as the type of cancer, the specific chemotherapy regimen, and the patient's overall health status. Commonly used forms of G-CSF include filgrastim and pegfilgrastim.
